Blucora, Inc. (BCOR) Tops Q3 EPS by 7c

Blucora, Inc. (NASDAQ: BCOR) reported Q3 EPS of ($0.12), $0.07 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $90.2 million versus the consensus estimate of $89.47 million.

For earnings history and earnings-related data on Blucora, Inc. (BCOR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c